BRCA1 and pancreatic adenocarcinoma: This paper will examine the landscape of DDR-associated gene mutations in pancreatic adenocarcinomas and therapeutic development of drugs targeting the process, with a focus on cancers with both germline and somatic alterations in BRCA1 and BRCA2 and cases with mutations in DDR genes other than BRCA1 and BRCA2.